MGH Researchers Develop AI Tool to Predict Melanoma Recurrence A team of scientists at Massachusetts General Hospital has developed a new tool that uses AI to predict which patients are most likely to experience a recurrence of melanoma. Read the blog to learn how this research may lead to more effective treatment for patients in the early stages of melanoma. Contact Us: 202.293.5003 x4 sales@madwolf.com